Prostaglandin F2 alpha stimulates inositol phosphate production in human pregnant myometrium

Prostaglandins. 1993 Mar;45(3):269-83. doi: 10.1016/0090-6980(93)90052-9.

Abstract

We examined the effect of prostaglandin F2 alpha (PGF2 alpha) on phosphoinositide (PI)-hydrolysis in the outer layer of the human myometrium at the end of pregnancy. After pretreatment of myometrial explants with a cyclo-oxygenase inhibitor (indomethacin), the PGF2 alpha dose-response curve was shifted to the left and a maximal level of PGF2 alpha-induced IP accumulation was reached. In contrast, the well-known OT-induced IP accumulation was decreased in the presence of indomethacin, whereas potency was unchanged. Incubation of the myometrial explants with calcium-depleted medium, not only decreased the basal IP production but completely abolished the OT- and PGF2 alpha-induced IP accumulation. A L-type calcium channel inhibitor, verapamil 100 microM, significantly decreased PGF2 alpha-induced total inositol production whereas it had no effect on OT-response, suggesting that the first event of PGF2 alpha action is the activation of a calcium channel. These results point to marked differences in the mechanisms by which OT and PGF2 alpha exert their contractile effects in human myometrium at the end of pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / physiology
  • Culture Techniques
  • Dinoprost / pharmacology*
  • Female
  • Humans
  • Indomethacin / pharmacology
  • Inositol Phosphates / biosynthesis*
  • Myometrium / drug effects*
  • Myometrium / metabolism
  • Oxytocin / pharmacology
  • Pregnancy / metabolism*

Substances

  • Inositol Phosphates
  • Oxytocin
  • Dinoprost
  • Calcium
  • Indomethacin